AW
ESPR

Avion Wealth’s Esperion Therapeutics ESPR Stock Holding History

Avion Wealth’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Sell
5,000
-5,000
-50% -$14K ﹤0.01% 460
2026
Q1 		$27K Hold
10,000
– – 0.01% 283
2025
Q4 		$37K Hold
10,000
– – 0.01% 247
2025
Q3 		$26K Hold
10,000
– – 0.01% 299
2025
Q2 		$9K Buy
10,000
+2,000
+25% +$2K ﹤0.01% 496
2025
Q1 		$17K Hold
8,000
– – ﹤0.01% 308
2024
Q4 		$17K Hold
8,000
– – ﹤0.01% 308
2024
Q3 		$13K Buy
8,000
+1,000
+14% +$2.02K ﹤0.01% 322
2024
Q2 		$15K Buy
7,000
+5,000
+250% +$11.8K ﹤0.01% 264
2024
Q1 		$6K Buy
+2,000
New +$4.86K ﹤0.01% 415

Other funds holding ESPR

GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return

Avion Wealth's ESPR Position: Q2 2026 in Review

Avion Wealth reduced its Esperion Therapeutics (ESPR) stake by 50% in Q2 2026, selling an estimated $14K and leaving 5,000 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #460.

Avion Wealth first reported a position in ESPR in Q1 2024 and has held it in 10 quarters since. The position peaked at $37K in Q4 2025. 191 funds tracked by Wall St. Rank hold ESPR as of Q2 2026.

  • Avion Wealth held 5,000 shares of Esperion Therapeutics worth $15K as of Q2 2026.
  • Avion Wealth sold 5,000 Esperion Therapeutics shares in Q2 2026, an estimated $14K.
  • Esperion Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #460 holding.
  • Avion Wealth first reported a position in Esperion Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Avion Wealth's Esperion Therapeutics position peaked at $37K in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.